Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

December 1, 2022

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Restrata®

Restrata® is a sterile, single use device intended for use in local management of wounds. Restrata® is a soft, white, conformable, non-friable, absorbable matrix that provides a moist environment for the body's natural healing process to occur. Restrata® is made from synthetic biocompatible materials and was designed to include a fibrous structure with high porosity, similar to native extracellular matrix.

DEVICE

Wound Dressing

Alginate or Foam wound dressing is intended to manage wounds.

Trial Locations (1)

60169

Midwest Foot and Ankle Clinics, Hoffman Estates

Sponsors
All Listed Sponsors
lead

Acera Surgical, Inc.

INDUSTRY

NCT04918784 - Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter